Research that began in 2009 finally completed its long trek through patent approval.  Titled, "Methods for inducing an immune response via buccal and/or sublingual administration of a vaccine", this patent provides a stable legal foundation as we find ourselves approached by more potential investors from the pharmaceutical industry.
U.S. Patent: 9,675,550